EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BMP3b regulates bone mass by inhibiting BMP signaling

Nao Kodama, Takuma Matsubara, Anna Yoshimura, Kenichi Nagano, Jun Hino, Kunikazu Tsuji, Aoi Ikedo, Yuuki Imai, Tatsuki Yaginuma, Quan Yuan, Kazumasa Morikawa, Yusuke Ono und 4 weitere

Bone · 2025

DOI: 10.1016/j.bone.2024.117303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2025. Verfasst von Nao Kodama und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, Kitakyushu, Fukuoka 803-8580, Japan; Di…. Hauptthemen laut MEDLINE: Signal Transduction, Osteogenesis, Osteoblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone morphogenetic protein 3b (BMP3b), also known as growth differentiation factor 10 (GDF10), is a non-osteogenic BMP highly expressed in the skeleton. Although in vitro studies have shown that BMP3b suppresses osteoblast differentiation, the physiological role of BMP3b in regulating bone mass in vivo remains unknown. Here, we show that BMP3b deletion in mice leads to a high bone mass phenotype via an unexpected novel mechanism involving de-repression of canonical BMP/Smad signaling. BMP3b null mice were viable, and exhibited no significant difference in body size compared to wildtype control. Trabecular bone parameters assessed by histomorphometry and μCT, revealed a significant increase in bone volume and bone mineral density. Expression of osteoblast-differentiation genes were elevated in bone tissue of BMP3b null mice, whereas expression of osteoclast-related genes remained unchanged. Consistent with this, Bmp3b was highly expressed in osteoblasts relative to osteoclast cells. Ex-vivo culture of primary bone marrow mesenchymal stem cells (BMSCs) and primary bone marrow-derived osteoclasts revealed that inactivation of BMP3b enhances osteogenesis without affecting osteoclastogenesis. Mechanistically, we found that BMP3b suppressed BMP4-induced Smad1/5 phosphorylation and inhibited the activity of a BMP4-driven Id-1 luciferase reporter. Protein-protein interaction assays revealed that BMP3b competitively interfered with the association of BMP4 and BMP type I receptors. These findings suggest that BMP3b regulates bone mass by acting as a BMP receptor antagonist. Thus, maintenance of bone mass involves antagonism of canonical BMP/Smad signaling by a member of the BMP family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionOsteogenesisOsteoblastsAnimalsGrowth Differentiation Factor 10MiceBone and BonesMice, KnockoutOsteoclastsCell DifferentiationMesenchymal Stem CellsOrgan SizeBone DensitySmad ProteinsMice, Inbred C57BLBone Morphogenetic Protein 4Phosphorylation

Stichwörter der Autor:innen

BMP3bBone formationBone marrow stromal cellsBone massOsteoblasts

Substanzen

Growth Differentiation Factor 10Smad ProteinsBone Morphogenetic Protein 4

Autor:innen und Institutionen

  • Division of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, Kitakyushu, Fukuoka 803-8580, Japan; Division of Oral Medicine, Kyushu Dental University, Kokurakita, Kitakyu…
  • Division of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, Kitakyushu, Fukuoka 803-8580, Japan.
  • Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan.
  • Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Japan.
  • Department of Orthopedic Surgery, Tokyo Medical and Dental University (Institute of Science Tokyo), Tokyo, Japan.
  • Division of Integrative Pathophysiology, Proteo-Science Center, Ehime University Graduate School of Medicine, Toon City, Ehime, Japan.

Zitieren

APA

Kodama, N., Matsubara, T., Yoshimura, A., Nagano, K., Hino, J., Tsuji, K., Ikedo, A., Imai, Y., Yaginuma, T., Yuan, Q., Morikawa, K., Ono, Y., Shirakawa, T., Addison, W. N., Yoshioka, I., & Kokabu, S. (2025). BMP3b regulates bone mass by inhibiting BMP signaling. Bone. https://doi.org/10.1016/j.bone.2024.117303

Vancouver

Kodama N, Matsubara T, Yoshimura A, Nagano K, Hino J, Tsuji K, et al. BMP3b regulates bone mass by inhibiting BMP signaling. Bone. 2025. doi:10.1016/j.bone.2024.117303

BibTeX
@article{Kodama2025,
  author = {Kodama, Nao and Matsubara, Takuma and Yoshimura, Anna and Nagano, Kenichi and Hino, Jun and Tsuji, Kunikazu and Ikedo, Aoi and Imai, Yuuki and Yaginuma, Tatsuki and Yuan, Quan and Morikawa, Kazumasa and Ono, Yusuke and Shirakawa, Tomohiko and Addison, William N and Yoshioka, Izumi and Kokabu, Shoichiro},
  title = {BMP3b regulates bone mass by inhibiting BMP signaling},
  journal = {Bone},
  year = {2025},
  doi = {10.1016/j.bone.2024.117303}
}
Kostenlos starten →